Skip to main content
logo
Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
26.58
-0.08 (-0.30%)
Sep 29, 2026, 4:00 PM EDT - Market closed

Alto Neuroscience Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.21
Revenue Growth
------
Gross Profit
-----0.21
Operating Income
-88.27-66.36-68.61-37.81-29.19-12.06
Net Income
-84.24-63.24-61.43-36.31-27.71-9.19
Earnings Per Share
-2.38-2.19-2.50-9.73-8.04-3.81
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
243.73176.48168.2382.5548.3425.71
Total Debt
23.2923.9616.949.999.87-
Net Cash (Debt)
220.44152.53151.2972.5638.4725.71
Net Cash Growth
83.28%0.82%108.49%88.61%49.67%-
Net Cash Per Share
6.235.296.1519.4511.1610.65

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-68.29-51.77-47.42-33.45-20.39-9.26
Capital Expenditures
-0.56-0.02-2.08-0.47-0.73-0.68
Free Cash Flow
-68.84-51.79-49.5-33.92-21.13-9.94
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----100.00%
Operating Margin
------5740.95%
Pretax Margin
------4374.76%
Profit Margin
------4374.76%
FCF Margin
------4734.29%

Valuation
Selected indicators aren't available for this stock.